Icenews is an independent news resource on Iceland, Scandinavia and Northern Europe. The following is a summary top 5 news stories for week 48 from around the world is brought to you by www.icenews.is .

Company aims to develop pharmaceutical therapeutics for blinding eye diseases, including Age-Related Macular Degeneration and Diabetic Retinopathy

Sequence XO, a nutritional supplement company focused on providing products exclusivly to Spas anounces the release of its newest product, Radiance.

Unique Diaton tonometer will be presented at the International Vision Expo and Conference on March 22-25th. Diaton will be showcased by BiCOM Inc. and Optimetrics Inc. The demo and training will be provided at Booth MS1252. BiCOM CEO comments on the Eye-market.

The British medical agency MHRA will soon issue new warnings for Strattera but didn't care to investigate the reported 12000 "psychiatric reactions" from the drug. And even if number of reports of suicidality has doubled since last year the MHRA has accepted the PR-analysis of Eli Lilly as its own.

Speaking on antidepressants the Vice President of The Swedish Psychiatric Association, Dr. Christina Spjut, said Sunday that "an immense number of persons get worse from this". She said that many persons take these drugs for years "where the antidepressant drugs make them continue to be depressed".

Learn about Juvista that can significantly reduce existing scars with only two injections.

The Era of Agel is transforming the wellness industry by merging cutting edge science in nutrition with revolutionary technology and convenience.

Blue Membranes and Goodman announce the closing of collaborative product development and a worldwide licence, manufacturing and supply agreement for BlueM's proprietary nano-composite drug-delivery coating technology.

Campaign launched to rally Multiple Sclerosis patients in potential class action lawsuit against the manufacturer of pharmaceutical drugs Tysabri and Avonex.

Internationally-acclaimed neuroscientist/researcher Candace Pert, Ph.D. and research colleague Michael Ruff, Ph.D. report on AIDS research now in clinical trials (for human patients) that promises to reduce the spread of AIDS, prolong life, reverse weight loss and offer earlier intervention.

Michael Bennett, M.D., Honolulu retinal surgeon, is able to offer the first real hope to his patients who face blindness from age-related macular degeneration.

Rimonabant Report to Cover All of the Latest Rimonabant Trial Results and Related News Briefings at American College of Cardiology Meeting in Orlando